These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24584782)

  • 1. Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells.
    Dang L; Wen F; Yang Y; Liu D; Wu K; Qi Y; Li X; Zhao J; Zhu D; Zhang C; Zhao S
    Int J Mol Med; 2014 May; 33(5):1083-8. PubMed ID: 24584782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth.
    Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J
    Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
    Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
    PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
    Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S
    Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin enhances apoptosis induced by cisplatin in human esophageal squamous cell carcinoma EC9706 cells related to inhibition of autophagy.
    Yang Y; Wen F; Dang L; Fan Y; Liu D; Wu K; Zhao S
    Chin Med J (Engl); 2014; 127(2):353-8. PubMed ID: 24438628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL-mediated apoptosis.
    Yoshiba S; Iwase M; Kurihara S; Uchida M; Kurihara Y; Watanabe H; Shintani S
    Oncol Rep; 2011 Mar; 25(3):645-52. PubMed ID: 21206980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma.
    Xu Y; Zhou L; Huang J; Liu F; Yu J; Zhan Q; Zhang L; Zhao X
    Clin Cancer Res; 2011 Aug; 17(16):5412-22. PubMed ID: 21676925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells.
    Sun SJ; Feng L; Zhao GQ; Dong ZM
    Dig Dis Sci; 2012 Jul; 57(7):1838-46. PubMed ID: 22451114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
    Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo.
    Guo N; Peng Z; Zhang J
    Int J Gynecol Cancer; 2016 Jun; 26(5):839-44. PubMed ID: 27051056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
    Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
    Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.
    Chen L; Pan J
    Br J Pharmacol; 2017 Aug; 174(15):2427-2443. PubMed ID: 28444744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
    Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
    Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
    Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells.
    Zhu L; Du H; Shi M; Chen Z; Hang J
    Bull Cancer; 2013; 100(7-8):15-21. PubMed ID: 23823853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.